The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Anti-Infective Medications Market Research Report 2025
Synopsis
OTC anti-infective medications are over-the-counter (OTC) drugs that are used to treat infections. These medications are commonly used to treat a wide range of infections, including respiratory, urinary tract, and skin infections.
OTC anti-infective medications include antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are used to treat bacterial infections, while antivirals are used to treat viral infections. Antifungals are used to treat fungal infections, and antiparasitics are used to treat parasite infections.
The global OTC Anti-Infective Medications market was valued at US$ 85480 million in 2023 and is anticipated to reach US$ 122040 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Medications.
Report Scope
The OTC Anti-Infective Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Anti-Infective Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma
Segment by Type
Antifungals
Antiseptic
Antiparasitics
Segment by Application
Hospital Pharmacies
Drug Stores
E-Commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Anti-Infective Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
OTC anti-infective medications are over-the-counter (OTC) drugs that are used to treat infections. These medications are commonly used to treat a wide range of infections, including respiratory, urinary tract, and skin infections.
OTC anti-infective medications include antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are used to treat bacterial infections, while antivirals are used to treat viral infections. Antifungals are used to treat fungal infections, and antiparasitics are used to treat parasite infections.
The global OTC Anti-Infective Medications market was valued at US$ 85480 million in 2023 and is anticipated to reach US$ 122040 million by 2030, witnessing a CAGR of 5.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Medications.
Report Scope
The OTC Anti-Infective Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Anti-Infective Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Pfizer
Novartis
Abbott
Sanofi
Bristol-Myers Squibb
Roche
NanoViricides
Novabay Pharmaceuticals
Optimer Pharmaceuticals
Basilea Pharmaceutica
MerLion Pharma
Segment by Type
Antifungals
Antiseptic
Antiparasitics
Segment by Application
Hospital Pharmacies
Drug Stores
E-Commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Anti-Infective Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antifungals
1.2.3 Antiseptic
1.2.4 Antiparasitics
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Medications Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-Infective Medications Market Perspective (2019-2030)
2.2 OTC Anti-Infective Medications Growth Trends by Region
2.2.1 Global OTC Anti-Infective Medications Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 OTC Anti-Infective Medications Historic Market Size by Region (2019-2024)
2.2.3 OTC Anti-Infective Medications Forecasted Market Size by Region (2025-2030)
2.3 OTC Anti-Infective Medications Market Dynamics
2.3.1 OTC Anti-Infective Medications Industry Trends
2.3.2 OTC Anti-Infective Medications Market Drivers
2.3.3 OTC Anti-Infective Medications Market Challenges
2.3.4 OTC Anti-Infective Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Anti-Infective Medications Players by Revenue
3.1.1 Global Top OTC Anti-Infective Medications Players by Revenue (2019-2024)
3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2019-2024)
3.2 Global OTC Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Anti-Infective Medications Revenue
3.4 Global OTC Anti-Infective Medications Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Medications Revenue in 2023
3.5 OTC Anti-Infective Medications Key Players Head office and Area Served
3.6 Key Players OTC Anti-Infective Medications Product Solution and Service
3.7 Date of Enter into OTC Anti-Infective Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Medications Breakdown Data by Type
4.1 Global OTC Anti-Infective Medications Historic Market Size by Type (2019-2024)
4.2 Global OTC Anti-Infective Medications Forecasted Market Size by Type (2025-2030)
5 OTC Anti-Infective Medications Breakdown Data by Application
5.1 Global OTC Anti-Infective Medications Historic Market Size by Application (2019-2024)
5.2 Global OTC Anti-Infective Medications Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America OTC Anti-Infective Medications Market Size (2019-2030)
6.2 North America OTC Anti-Infective Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America OTC Anti-Infective Medications Market Size by Country (2019-2024)
6.4 North America OTC Anti-Infective Medications Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Anti-Infective Medications Market Size (2019-2030)
7.2 Europe OTC Anti-Infective Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe OTC Anti-Infective Medications Market Size by Country (2019-2024)
7.4 Europe OTC Anti-Infective Medications Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Medications Market Size (2019-2030)
8.2 Asia-Pacific OTC Anti-Infective Medications Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2019-2024)
8.4 Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Anti-Infective Medications Market Size (2019-2030)
9.2 Latin America OTC Anti-Infective Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America OTC Anti-Infective Medications Market Size by Country (2019-2024)
9.4 Latin America OTC Anti-Infective Medications Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Medications Market Size (2019-2030)
10.2 Middle East & Africa OTC Anti-Infective Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2019-2024)
10.4 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck OTC Anti-Infective Medications Introduction
11.2.4 Merck Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OTC Anti-Infective Medications Introduction
11.3.4 Pfizer Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis OTC Anti-Infective Medications Introduction
11.4.4 Novartis Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott OTC Anti-Infective Medications Introduction
11.5.4 Abbott Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi OTC Anti-Infective Medications Introduction
11.6.4 Sanofi Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.6.5 Sanofi Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Introduction
11.7.4 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche OTC Anti-Infective Medications Introduction
11.8.4 Roche Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.8.5 Roche Recent Development
11.9 NanoViricides
11.9.1 NanoViricides Company Detail
11.9.2 NanoViricides Business Overview
11.9.3 NanoViricides OTC Anti-Infective Medications Introduction
11.9.4 NanoViricides Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.9.5 NanoViricides Recent Development
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Company Detail
11.10.2 Novabay Pharmaceuticals Business Overview
11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Introduction
11.10.4 Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.10.5 Novabay Pharmaceuticals Recent Development
11.11 Optimer Pharmaceuticals
11.11.1 Optimer Pharmaceuticals Company Detail
11.11.2 Optimer Pharmaceuticals Business Overview
11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Introduction
11.11.4 Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.11.5 Optimer Pharmaceuticals Recent Development
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Company Detail
11.12.2 Basilea Pharmaceutica Business Overview
11.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Introduction
11.12.4 Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.12.5 Basilea Pharmaceutica Recent Development
11.13 MerLion Pharma
11.13.1 MerLion Pharma Company Detail
11.13.2 MerLion Pharma Business Overview
11.13.3 MerLion Pharma OTC Anti-Infective Medications Introduction
11.13.4 MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2019-2024)
11.13.5 MerLion Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antifungals
Table 3. Key Players of Antiseptic
Table 4. Key Players of Antiparasitics
Table 5. Global OTC Anti-Infective Medications Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global OTC Anti-Infective Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global OTC Anti-Infective Medications Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global OTC Anti-Infective Medications Market Share by Region (2019-2024)
Table 9. Global OTC Anti-Infective Medications Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global OTC Anti-Infective Medications Market Share by Region (2025-2030)
Table 11. OTC Anti-Infective Medications Market Trends
Table 12. OTC Anti-Infective Medications Market Drivers
Table 13. OTC Anti-Infective Medications Market Challenges
Table 14. OTC Anti-Infective Medications Market Restraints
Table 15. Global OTC Anti-Infective Medications Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global OTC Anti-Infective Medications Market Share by Players (2019-2024)
Table 17. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2023)
Table 18. Ranking of Global Top OTC Anti-Infective Medications Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by OTC Anti-Infective Medications Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players OTC Anti-Infective Medications Product Solution and Service
Table 22. Date of Enter into OTC Anti-Infective Medications Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global OTC Anti-Infective Medications Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global OTC Anti-Infective Medications Revenue Market Share by Type (2019-2024)
Table 26. Global OTC Anti-Infective Medications Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global OTC Anti-Infective Medications Revenue Market Share by Type (2025-2030)
Table 28. Global OTC Anti-Infective Medications Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global OTC Anti-Infective Medications Revenue Market Share by Application (2019-2024)
Table 30. Global OTC Anti-Infective Medications Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global OTC Anti-Infective Medications Revenue Market Share by Application (2025-2030)
Table 32. North America OTC Anti-Infective Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America OTC Anti-Infective Medications Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America OTC Anti-Infective Medications Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe OTC Anti-Infective Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe OTC Anti-Infective Medications Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe OTC Anti-Infective Medications Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific OTC Anti-Infective Medications Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America OTC Anti-Infective Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America OTC Anti-Infective Medications Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America OTC Anti-Infective Medications Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa OTC Anti-Infective Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2025-2030) & (US$ Million)
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline OTC Anti-Infective Medications Product
Table 50. GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. Merck Company Detail
Table 53. Merck Business Overview
Table 54. Merck OTC Anti-Infective Medications Product
Table 55. Merck Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 56. Merck Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer OTC Anti-Infective Medications Product
Table 60. Pfizer Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis OTC Anti-Infective Medications Product
Table 65. Novartis Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Abbott Company Detail
Table 68. Abbott Business Overview
Table 69. Abbott OTC Anti-Infective Medications Product
Table 70. Abbott Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Sanofi Company Detail
Table 73. Sanofi Business Overview
Table 74. Sanofi OTC Anti-Infective Medications Product
Table 75. Sanofi Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. Bristol-Myers Squibb Company Detail
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb OTC Anti-Infective Medications Product
Table 80. Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Roche Company Detail
Table 83. Roche Business Overview
Table 84. Roche OTC Anti-Infective Medications Product
Table 85. Roche Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 86. Roche Recent Development
Table 87. NanoViricides Company Detail
Table 88. NanoViricides Business Overview
Table 89. NanoViricides OTC Anti-Infective Medications Product
Table 90. NanoViricides Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 91. NanoViricides Recent Development
Table 92. Novabay Pharmaceuticals Company Detail
Table 93. Novabay Pharmaceuticals Business Overview
Table 94. Novabay Pharmaceuticals OTC Anti-Infective Medications Product
Table 95. Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 96. Novabay Pharmaceuticals Recent Development
Table 97. Optimer Pharmaceuticals Company Detail
Table 98. Optimer Pharmaceuticals Business Overview
Table 99. Optimer Pharmaceuticals OTC Anti-Infective Medications Product
Table 100. Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 101. Optimer Pharmaceuticals Recent Development
Table 102. Basilea Pharmaceutica Company Detail
Table 103. Basilea Pharmaceutica Business Overview
Table 104. Basilea Pharmaceutica OTC Anti-Infective Medications Product
Table 105. Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 106. Basilea Pharmaceutica Recent Development
Table 107. MerLion Pharma Company Detail
Table 108. MerLion Pharma Business Overview
Table 109. MerLion Pharma OTC Anti-Infective Medications Product
Table 110. MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2019-2024) & (US$ Million)
Table 111. MerLion Pharma Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Anti-Infective Medications Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global OTC Anti-Infective Medications Market Share by Type: 2023 VS 2030
Figure 3. Antifungals Features
Figure 4. Antiseptic Features
Figure 5. Antiparasitics Features
Figure 6. Global OTC Anti-Infective Medications Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global OTC Anti-Infective Medications Market Share by Application: 2023 VS 2030
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Drug Stores Case Studies
Figure 10. E-Commerce Case Studies
Figure 11. OTC Anti-Infective Medications Report Years Considered
Figure 12. Global OTC Anti-Infective Medications Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global OTC Anti-Infective Medications Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global OTC Anti-Infective Medications Market Share by Region: 2023 VS 2030
Figure 15. Global OTC Anti-Infective Medications Market Share by Players in 2023
Figure 16. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by OTC Anti-Infective Medications Revenue in 2023
Figure 18. North America OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America OTC Anti-Infective Medications Market Share by Country (2019-2030)
Figure 20. United States OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe OTC Anti-Infective Medications Market Share by Country (2019-2030)
Figure 24. Germany OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific OTC Anti-Infective Medications Market Share by Region (2019-2030)
Figure 32. China OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America OTC Anti-Infective Medications Market Share by Country (2019-2030)
Figure 40. Mexico OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa OTC Anti-Infective Medications Market Share by Country (2019-2030)
Figure 44. Turkey OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia OTC Anti-Infective Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. GlaxoSmithKline Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 47. Merck Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 49. Novartis Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 50. Abbott Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 51. Sanofi Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 53. Roche Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 54. NanoViricides Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 55. Novabay Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 56. Optimer Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 57. Basilea Pharmaceutica Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 58. MerLion Pharma Revenue Growth Rate in OTC Anti-Infective Medications Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
